• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有阿尔茨海默病家族史的正常个体中的氧化应激和淀粉样-β 病理学。

Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.

机构信息

Center for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, New York 10016, USA.

出版信息

Biol Psychiatry. 2010 Nov 15;68(10):913-21. doi: 10.1016/j.biopsych.2010.07.011.

DOI:10.1016/j.biopsych.2010.07.011
PMID:20817151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2967599/
Abstract

BACKGROUND

Epidemiology and imaging studies showed that cognitively normal (NL) individuals with a maternal history (MH) of late-onset Alzheimer's disease (LOAD) might be at increased risk for Alzheimer's disease (AD) compared with NL with a paternal history (PH) and NL with a negative family history of LOAD (NH). With a panel of cerebrospinal fluid (CSF) markers, this study examined whether NL MH showed evidence for AD pathology compared with PH and NH.

METHODS

Fifty-nine 40-80-year-old NL subjects were examined, including 23 MH and 14 PH whose parents had a clinician-certified diagnosis of LOAD and 22 NH. All subjects completed clinical neuropsychological examinations and a lumbar puncture to measure CSF levels of amyloid-beta (Aβ(40), Aβ(42), Aβ(42/40)), total and hyperphosphorylated tau (T-Tau and P-Tau(231); markers of axonal degeneration and neurofibrillary tangles, respectively), and F₂-isoprostanes (IsoP) (a marker of oxidative stress).

RESULTS

Groups were comparable for demographic and neuropsychological measures. The MH subjects showed higher IsoP and reduced Aβ(42/40) CSF levels compared with NH and with PH (p values ≤ .05), whereas no differences were found between NH and PH. No group differences were found for P-Tau(231) and T-Tau. The IsoP and Aβ(42/40) levels were correlated only within the MH group (R² = .32, p = .005) and discriminated MH from the other subjects with 70% accuracy (relative risk = 3.7%, 95% confidence interval = 1.6-9.7, p < .001). Results remained significant controlling for age, gender, education, and apolipoprotein E genotype.

CONCLUSIONS

Adult children of LOAD-affected mothers express a pathobiological phenotype characterized by Aβ-associated oxidative stress consistent with AD, which might reflect increased risk for developing the disease.

摘要

背景

流行病学和影像学研究表明,与有父系家族史(PH)和无 LOAD 家族史(NH)的认知正常(NL)个体相比,有 LOAD 母系家族史(MH)的 NL 个体发生阿尔茨海默病(AD)的风险可能增加。本研究采用一组脑脊液(CSF)标志物,旨在探讨 NL MH 是否与 PH 和 NH 相比存在 AD 病理证据。

方法

共纳入 59 名 40-80 岁 NL 受试者,其中 23 名 MH、14 名 PH,其父母均经临床医生确诊为 LOAD,22 名 NH。所有受试者均完成了临床神经心理学检查和腰椎穿刺,以测量 CSF 中淀粉样β(Aβ(40)、Aβ(42)、Aβ(42/40))、总 tau(T-Tau)和磷酸化 tau(P-Tau(231))(分别为轴突退变和神经原纤维缠结的标志物)和 F₂-异前列腺素(IsoP)(氧化应激标志物)的水平。

结果

各组在人口统计学和神经心理学指标方面无差异。与 NH 和 PH 相比,MH 受试者的 IsoP 水平较高,Aβ(42/40)CSF 水平较低(p 值均≤.05),而 NH 和 PH 之间无差异。各组之间 P-Tau(231)和 T-Tau 水平无差异。仅在 MH 组中,IsoP 和 Aβ(42/40)水平之间存在相关性(R² =.32,p =.005),且 IsoP 和 Aβ(42/40)可将 MH 与其他受试者区分开来,其准确率为 70%(相对风险 = 3.7%,95%置信区间 = 1.6-9.7,p <.001)。在校正年龄、性别、教育程度和载脂蛋白 E 基因型后,结果仍有统计学意义。

结论

LOAD 患者的成年子女表现出一种以 Aβ 相关氧化应激为特征的病理表型,这与 AD 一致,这可能反映出他们发生该病的风险增加。

相似文献

1
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.有阿尔茨海默病家族史的正常个体中的氧化应激和淀粉样-β 病理学。
Biol Psychiatry. 2010 Nov 15;68(10):913-21. doi: 10.1016/j.biopsych.2010.07.011.
2
Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer's disease as identified by biomarkers.脑脊液中 F2-异前列腺素含量的增加与衰老和通过生物标志物识别的潜伏性阿尔茨海默病有关。
Neuromolecular Med. 2011 Mar;13(1):37-43. doi: 10.1007/s12017-010-8126-6. Epub 2010 Jul 15.
3
Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.脑脊液生物标志物与阿尔茨海默病风险之间的共享遗传背景:两样本孟德尔随机化研究。
J Alzheimers Dis. 2021;80(3):1197-1207. doi: 10.3233/JAD-200671.
4
Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease.磁共振成像可改善脑脊液生物标志物在阿尔茨海默病早期检测中的应用。
J Alzheimers Dis. 2009;16(2):351-62. doi: 10.3233/JAD-2009-0968.
5
Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer's disease.阿尔茨海默病母亲的成年子女中线粒体细胞色素氧化酶活性降低。
J Alzheimers Dis. 2011;27(3):483-90. doi: 10.3233/JAD-2011-110866.
6
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.遗传风险作为脑脊液中β淀粉样蛋白和tau蛋白负荷的标志物
J Alzheimers Dis. 2017;55(4):1417-1427. doi: 10.3233/JAD-160707.
7
Association of oxidative stress and inflammatory metabolites with Alzheimer's disease cerebrospinal fluid biomarkers in mild cognitive impairment.氧化应激和炎症代谢物与轻度认知障碍阿尔茨海默病脑脊液生物标志物的关联。
Alzheimers Res Ther. 2024 Jul 30;16(1):171. doi: 10.1186/s13195-024-01542-4.
8
Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.认知正常老年人中,睡眠呼吸障碍与载脂蛋白E基因型对阿尔茨海默病脑脊液生物标志物的相互作用。
Neurobiol Aging. 2014 Jun;35(6):1318-24. doi: 10.1016/j.neurobiolaging.2013.12.030. Epub 2013 Dec 27.
9
Maternal family history is associated with Alzheimer's disease biomarkers.母系家族史与阿尔茨海默病生物标志物有关。
J Alzheimers Dis. 2012;31(3):659-68. doi: 10.3233/JAD-2012-120676.
10
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.阿尔茨海默病标准化脑脊液生物标志物在澳大利亚成像、生物标志物和生活方式(AIBL)研究中经PET淀粉样β蛋白特征化的受试者中得到验证。
J Alzheimers Dis. 2015;48(1):175-87. doi: 10.3233/JAD-150247.

引用本文的文献

1
The role of n-3-derived specialised pro-resolving mediators (SPMs) in microglial mitochondrial respiration and inflammation resolution in Alzheimer's disease.n-3衍生的特异性促消退介质(SPMs)在阿尔茨海默病小胶质细胞线粒体呼吸和炎症消退中的作用
Mol Neurodegener. 2025 Mar 21;20(1):35. doi: 10.1186/s13024-025-00824-1.
2
Parental history of dementia and the risk of dementia: A cross-sectional analysis of a global collaborative study.痴呆症的家族史与痴呆症的风险:一项全球性合作研究的横断面分析。
Psychiatry Clin Neurosci. 2023 Aug;77(8):449-456. doi: 10.1111/pcn.13561. Epub 2023 May 24.
3
Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease.家族性阿尔茨海默病患者楔前叶功能连接增加。
J Alzheimers Dis. 2023;91(2):559-571. doi: 10.3233/JAD-210326.
4
Editorial: Metabolism in Alzheimer's Disease.社论:阿尔茨海默病中的代谢
Front Neurosci. 2022 Jan 4;15:824145. doi: 10.3389/fnins.2021.824145. eCollection 2021.
5
Ketotherapeutics for neurodegenerative diseases.酮治疗神经退行性疾病。
Int Rev Neurobiol. 2020;155:141-168. doi: 10.1016/bs.irn.2020.02.003. Epub 2020 Aug 11.
6
The mitochondrial hypothesis: Dysfunction, bioenergetic defects, and the metabolic link to Alzheimer's disease.线粒体假说:功能障碍、生物能量缺陷以及与阿尔茨海默病的代谢联系。
Int Rev Neurobiol. 2020;154:207-233. doi: 10.1016/bs.irn.2020.01.008. Epub 2020 Jul 10.
7
Assessment of a Cognitive-Motor Training Program in Adults at Risk for Developing Dementia.对有患痴呆症风险的成年人进行认知-运动训练项目的评估。
Can Geriatr J. 2020 May 1;23(2):190-198. doi: 10.5770/cgj.23.394. eCollection 2020 Jun.
8
Comparison of TRho MRI, Glucose Metabolism, and Amyloid Burden Across the Cognitive Spectrum: A Pilot Study.认知谱上TRho MRI、葡萄糖代谢和淀粉样蛋白负荷的比较:一项初步研究。
J Neuropsychiatry Clin Neurosci. 2020 Fall;32(4):352-361. doi: 10.1176/appi.neuropsych.19100221. Epub 2020 Apr 14.
9
Mitochondria and Mitochondrial Cascades in Alzheimer's Disease.阿尔茨海默病中的线粒体和线粒体级联反应。
J Alzheimers Dis. 2018;62(3):1403-1416. doi: 10.3233/JAD-170585.
10
Mitochondria, Cybrids, Aging, and Alzheimer's Disease.线粒体、胞质杂种、衰老与阿尔茨海默病
Prog Mol Biol Transl Sci. 2017;146:259-302. doi: 10.1016/bs.pmbts.2016.12.017. Epub 2017 Feb 1.

本文引用的文献

1
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes.阿尔茨海默病的母系传递:前驱代谢表型和基因探寻。
Hum Genomics. 2010 Feb;4(3):170-93. doi: 10.1186/1479-7364-4-3-170.
2
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.家族中有晚发性阿尔茨海默病病史的正常个体中纤维状淀粉样-β负担增加。
Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5949-54. doi: 10.1073/pnas.0914141107. Epub 2010 Mar 15.
3
APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.载脂蛋白 E 预测认知正常衰老中的淀粉样-β 但不能预测 tau 阿尔茨海默病病理学。
Ann Neurol. 2010 Jan;67(1):122-31. doi: 10.1002/ana.21843.
4
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.阿尔茨海默病的脑脊液和血浆生物标志物。
Nat Rev Neurol. 2010 Mar;6(3):131-44. doi: 10.1038/nrneurol.2010.4. Epub 2010 Feb 16.
5
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.阿尔茨海默病病理级联的动态生物标志物假设模型。
Lancet Neurol. 2010 Jan;9(1):119-28. doi: 10.1016/S1474-4422(09)70299-6.
6
Association of parental dementia with cognitive and brain MRI measures in middle-aged adults.父母患痴呆与中年人大脑认知和 MRI 测量的相关性。
Neurology. 2009 Dec 15;73(24):2071-8. doi: 10.1212/WNL.0b013e3181c67833. Epub 2009 Dec 9.
7
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.轻度认知障碍患者的脑脊液生物标志物与早期阿尔茨海默病
JAMA. 2009 Jul 22;302(4):385-93. doi: 10.1001/jama.2009.1064.
8
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.淀粉样前体蛋白(APP)与死亡受体6(DR6)结合,通过不同的半胱天冬酶触发轴突修剪和神经元死亡。
Nature. 2009 Feb 19;457(7232):981-9. doi: 10.1038/nature07767.
9
Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease.有阿尔茨海默病家族病史的正常个体脑葡萄糖代谢下降。
Neurology. 2009 Feb 10;72(6):513-20. doi: 10.1212/01.wnl.0000333247.51383.43. Epub 2008 Nov 12.
10
Revised research diagnostic criteria for Alzheimer's disease.阿尔茨海默病修订研究诊断标准。
Lancet Neurol. 2008 Aug;7(8):668-70. doi: 10.1016/S1474-4422(08)70146-7.